• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Heart disease is the leading cause of death worldwide. Cardiomyopathy is a disease
characterized by the heart muscle damage, resulting heart in a structurally and functionally …

Cancer diagnostics and therapies have improved steadily over the last few decades,
markedly increasing life expectancy for patients at all ages. However, conventional and …

Although cardiosphere-derived cells (CDCs) improve cardiac function and outcomes in
patients with single ventricle physiology, little is known about their safety and therapeutic …

Hypertrophic cardiomyopathy (HCM) is a myocardial disease characterized by left
ventricular hypertrophy not solely explained by abnormal loading conditions. Despite its rare …

Genetic diseases that affect the cardiovascular system are relatively common and include
cardiac channelopathies, cardiomyopathies, aortopathies, hypercholesterolemias, and …

Cardiomyopathies (CMPs) are myocardial diseases in which the heart muscle is structurally
and functionally abnormal in the absence of coronary artery disease, hypertension, valvular …

Hypertrophic cardiomyopathy is a myocardial disease defined by an increased left
ventricular wall thickness not solely explained by abnormal loading conditions. It is often …

Background Causes and precipitating factors of sudden cardiac death (SCD) in adolescents
are poorly understood. Objectives The authors sought to investigate the etiologies of SCD …

This scientific statement from the American Heart Association focuses on treatment
strategies and modalities for cardiomyopathy (heart muscle disease) in children and serves …